Primary Biliary Cholangitis: What’s New?
Epidemiological studies on primary biliary cholangitis (CBP) have historically been based on case studies of third-level hospital and university centers. This may result in some distortions in the evaluation of the incidence and prevalence of the disease and of the associated diseases: it is known that the cases that are referred to specialist hospital centers are
typically more serious and complex.
The team of the Autoimmune Liver Health Center of the University of Milan - Bicocca at the San Gerardo Hospital in Monza, led by Prof. Pietro Invernizzi, chose a different method: he made use of the national database of hospital discharge records (SDO), which includes all Italian nationals discharged from any hospital in the country.
The objective of the work, conducted in collaboration with the Statistical Service of the Istituto Superiore di Sanità and published in the journal of Hepatology Communications, was to determine the incidence of CBP in hospitalized subjects and evaluate the most frequent comorbidities in this category of patients.
Dr. Alessio Gerussi, author of the study and PhD student at the Molecular and Translational Medicine Program of the University of Milan-Bicocca
Read Full article:
https://aasldpubs.onlinelibrary.wiley.com/doi/full/10.1002/hep4.1407
Other Insight:
https://www.sciencedirect.com/science/article/pii/S0002944019306248?via%3Dihub
Prof. Pietro Invernizzi & Dr. Alessio Gerussi
Recent Posts
- Lab Experience at the Laboratory of PLRD group – IR Sant Pau, Barcelona, Spain – Matteo Marinini
- Lab Experience at the Dino Ferrari Center – Gabriele Hamonet
- Lab Experience at the Istituto Nazionale dei Tumori – Anna Brozzoni
- Scientific Communication highlights from the Joint Core Course A.Y. 2024-25
- Lab Experience at the NIH National Institutes of Health USA – Davide Pizzi
